D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
+10.16%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$74.5B
AUM Growth
+$7.91B
Cap. Flow
-$5.9B
Cap. Flow %
-7.91%
Top 10 Hldgs %
15.59%
Holding
2,957
New
277
Increased
933
Reduced
1,194
Closed
329

Sector Composition

1 Technology 20.2%
2 Consumer Discretionary 16.12%
3 Healthcare 11.29%
4 Financials 8.38%
5 Communication Services 8.04%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
INGR icon
776
Ingredion
INGR
$8.08B
$10.9M 0.01%
143,838
+64,029
+80% +$4.85M
ALGT icon
777
Allegiant Air
ALGT
$1.17B
$10.9M 0.01%
90,565
+12,161
+16% +$1.46M
FOX icon
778
Fox Class B
FOX
$22.7B
$10.8M 0.01%
386,550
-137,286
-26% -$3.84M
CHRS icon
779
Coherus Oncology, Inc. Common Stock
CHRS
$156M
$10.8M 0.01%
586,634
-253,885
-30% -$4.66M
TDC icon
780
Teradata
TDC
$2B
$10.7M 0.01%
473,526
+41,318
+10% +$938K
SNDR icon
781
Schneider National
SNDR
$4.24B
$10.7M 0.01%
431,044
-31,461
-7% -$778K
HNI icon
782
HNI Corp
HNI
$2.08B
$10.6M 0.01%
338,741
-104,066
-24% -$3.27M
CCEP icon
783
Coca-Cola Europacific Partners
CCEP
$40.5B
$10.6M 0.01%
273,876
-101,229
-27% -$3.93M
DTE icon
784
DTE Energy
DTE
$28.1B
$10.6M 0.01%
108,516
-12,990
-11% -$1.27M
CERS icon
785
Cerus
CERS
$238M
$10.6M 0.01%
1,693,273
-273,058
-14% -$1.71M
IONS icon
786
Ionis Pharmaceuticals
IONS
$10.1B
$10.6M 0.01%
223,149
+110,277
+98% +$5.23M
PDD icon
787
Pinduoduo
PDD
$177B
$10.6M 0.01%
+142,687
New +$10.6M
CHNGU
788
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
$10.6M 0.01%
200,000
+150,000
+300% +$7.93M
FRPT icon
789
Freshpet
FRPT
$2.61B
$10.5M 0.01%
94,265
-96,264
-51% -$10.7M
RCUS icon
790
Arcus Biosciences
RCUS
$1.2B
$10.5M 0.01%
614,037
+168,755
+38% +$2.89M
CRUS icon
791
Cirrus Logic
CRUS
$5.76B
$10.5M 0.01%
155,755
-98,398
-39% -$6.64M
SUI icon
792
Sun Communities
SUI
$16.2B
$10.5M 0.01%
+74,438
New +$10.5M
KURA icon
793
Kura Oncology
KURA
$725M
$10.4M 0.01%
339,631
+76,174
+29% +$2.33M
ILMN icon
794
Illumina
ILMN
$14.9B
$10.4M 0.01%
34,602
-63,987
-65% -$19.2M
CDK
795
DELISTED
CDK Global, Inc.
CDK
$10.4M 0.01%
238,633
-89,572
-27% -$3.9M
OKTA icon
796
Okta
OKTA
$16.2B
$10.4M 0.01%
48,619
+27,159
+127% +$5.81M
TXT icon
797
Textron
TXT
$14.5B
$10.4M 0.01%
287,052
-354,541
-55% -$12.8M
LUMN icon
798
Lumen
LUMN
$6.2B
$10.4M 0.01%
1,026,487
-213,861
-17% -$2.16M
AVTA
799
DELISTED
Avantax, Inc. Common Stock
AVTA
$10.4M 0.01%
1,099,340
+337,357
+44% +$3.18M
PTGX icon
800
Protagonist Therapeutics
PTGX
$3.6B
$10.3M 0.01%
527,833
-285,113
-35% -$5.57M